<?xml version="1.0" encoding="UTF-8"?>
<p>In the RCT with patients with advanced HCC treated with 
 <italic>Coriolus versicolor</italic>, trends toward longer median OS compared to placebo (6.5 vs. 2.2 months, 
 <italic>Coriolus versicolor</italic> vs. placebo) and median progression-free survival (2.5 vs. 1.1 months) were observed (
 <xref rid="B9" ref-type="bibr">Chay et al., 2017</xref>). The time to progression (TTP) was not significant (2.5 vs. 4.2 months).
</p>
